Live Breaking News & Updates on Hedge Funds Weigh In On Processa Pharmaceuticals

Stay updated with breaking news from Hedge funds weigh in on processa pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Equities Analysts Set Expectations for Processa Pharmaceuticals, Inc.'s Q1 2025 Earnings (NASDAQ:PCSA)

Equities Analysts Set Expectations for Processa Pharmaceuticals, Inc.'s Q1 2025 Earnings (NASDAQ:PCSA)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Processa-pharmaceuticals-stock-performance , Processa-pharmaceuticals-company-profile , Nasdaq , Hedge-funds-weigh-in-on-processa-pharmaceuticals , Processa-pharmaceuticals , Securities-exchange-commission , News-ratings-for-processa-pharmaceuticals-daily , Processa-pharmaceuticals-inc , Free-report , Processa-pharmaceutical , Get-free-report

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) CEO George K. Ng Acquires 10,000 Shares of Stock

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) CEO George K. Ng purchased 10,000 shares of Processa Pharmaceuticals stock in a transaction that occurred on Tuesday, January 30th. The stock was acquired at an average price of $2.70 per share, with a total value of $27,000.00. Following the transaction, the chief executive officer now owns […] ....

Walleye-capital , Securities-exchange-commission , Processa-pharmaceuticals-inc , Maxim-group , Processa-pharmaceuticals-trading-down , Renaissance-technologies , News-ratings-for-processa-pharmaceuticals-daily , Processa-pharmaceuticals-company-profile , Nasdaq , Processa-pharmaceuticals , Raymond-james-financial-services-advisors-inc

Processa Pharmaceuticals (NASDAQ:PCSA) Shares Scheduled to Reverse Split on Monday, January 22nd

Shares of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) are set to reverse split before the market opens on Monday, January 22nd. The 1-20 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 22nd. Processa Pharmaceuticals Stock Performance NASDAQ […] ....

Raymond-james-financial-services-advisors-inc , Renaissance-technologies , Dimensional-fund-advisors , Nasdaq , Processa-pharmaceuticals-stock-performance , Hedge-funds-weigh-in-on-processa-pharmaceuticals , Sigma-securities , News-ratings-for-processa-pharmaceuticals-daily , Processa-pharmaceuticals , Processa-pharmaceuticals-inc , Maxim-group

Processa Pharmaceuticals (NASDAQ:PCSA) Shares Up 2.6%

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) shares shot up 2.6% during mid-day trading on Tuesday . The company traded as high as $0.57 and last traded at $0.56. 35,908 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 201,922 shares. The stock had previously closed at $0.55. […] ....

Patrick-lin , David-young , Raymond-james-financial-services-advisors-inc , News-ratings-for-processa-pharmaceuticals-daily , Dimensional-fund-advisors , Processa-pharmaceuticals , Sigma-securities , Nasdaq , Hedge-funds-weigh-in-on-processa-pharmaceuticals , Renaissance-technologies , Processa-pharmaceuticals-trading-down , Processa-pharmaceuticals-company-profile

UBS AG FI Enhanced Global High Yield ETN (NYSEARCA:FIHD) Stock Price Down 1.5%

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) shares shot up 2.6% during mid-day trading on Tuesday . The company traded as high as $0.57 and last traded at $0.56. 35,908 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 201,922 shares. The stock had previously closed at $0.55. […] ....

David-young , Patrick-lin , News-ratings-for-processa-pharmaceuticals-daily , Nasdaq , Raymond-james-financial-services-advisors-inc , Processa-pharmaceuticals-company-profile , Processa-pharmaceuticals , Dimensional-fund-advisors , Renaissance-technologies , Processa-pharmaceuticals-trading-down , Hedge-funds-weigh-in-on-processa-pharmaceuticals , Sigma-securities